Eating Disorders Clinical Trials | UCSD Health System

Eating Disorders Clinical Trials

Double-blind Placebo-controlled trial of Quetiapine (Seroquel) in Anorexia Nervosa

This research study is being held at UCSD to determine whether the medication Quetiapine helps people suffering from anorexia nervosa by reducing core eating disorders symptoms. This study will see if the medication Quetiapine helps symptoms of anxiety, depression, and obsessionality, in addition to increasing BMI. Men and women between the ages of 18-65 and are currently suffering from anorexia nervosa are needed. This study involves completion of: (a.) interviews, (b.) questionnaires, (c.) lab work, and (d.) medication management. The total time commitment for this study is approximately 18 hours, which will be spread out over the course of 8-10 weeks. The compensation for completion of this study and all related materials will be $360. HRPP#051027

To see if you qualify for this study, please contact Eating Disorders Research at (858) 366-2525.

Family Therapy and Fluoxetine in the Treatment of Adolescent Anorexia Nervosa

This research study is a multi-site study done at UCSD to investigate interventions for anorexia nervosa. Adolescents between the ages of 12-18, currently suffering from anorexia nervosa, and their families are needed. The treatments for this study will be provided free of charge and will involve weekly family therapy sessions in one of tow therapeutic approaches. Medication will also be administered throughout treatment, with participants receiving either Fluoxetine or a placebo. HRPP #051141

For more information about this research study or to see if you and your family qualify, please contact EDresearch@ucsd.edu or 858 366 2525